Michael Tranter, PhD, a researcher in the UC Heart, Lung and Vascular Institute, is shown in his laboratory in the College of Medicine. He is an assistant professor in the Division of Cardiovascular Health and Disease.

PHOTOS:

1

Michael Tranter, PhD, a researcher in the UC Heart, Lung and Vascular Institute, is shown in his laboratory in the College of Medicine. He is an assistant professor in the Division of Cardiovascular Health and Disease.

Michael Tranter, PhD, assistant professor in the Division of Cardiovascular Health and Disease, has been chosen for the 2017 Research Rising Star Award in the College of Medicine. Tranter completed his PhD in Molecular, Cellular and Biochemical Pharmacology at the University of Cincinnati in 2010 along with a two-year postdoctoral fellowship in UCís Department of Pharmacology and Cell Biophysics. He was retained as a faculty member in the Division of Cardiovascular Health and Disease in 2012. Tranterís research focuses on the mechanistic role of Human Antigen R (HuR) during the development and progression of pathological cardiac hypertrophy. Tranterís work has been funded by an American Heart Association Scientist Development Grant and an NIH-NHLBI R01 to study HuR as a novel mediator of cardiac hypertrophy; an NIH-NCAI sub-award and UC Technology Commercialization Accelerator Grant to commercialize a bioassay for detecting RNA-protein binding; and numerous internal grants.